Posted by on Oct 11, 2021 in Uncategorized |

[39] Since then, the practical impact of TRIPS and its flexibility on access to medicines, both within the commercial community and among public health experts, civil society groups and intergovernmental authorities, has continued to provoke intense debates. . . .